Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline

Neuroscience

Volumn 254, Issue , 2013, Pages 110-119

  Kauser, H ^a   Sahu, S ^a   Kumar, S ^a   Panjwani, U ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Dendritic morphology; Guanfacine; Hypobaric hypoxia; Prefrontal cortex

Indexed keywords

DOPAMINE; GUANFACINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ALTITUDE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITE; HYPOBARISM; HYPOXIA; MALE; MAZE TEST; NERVE INJURY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPINAL CORD NERVE CELL; TASK PERFORMANCE; WORKING MEMORY; ALTITUDE SICKNESS; ANIMAL; ANOXIA; COGNITION DISORDERS; DRUG EFFECTS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ALTITUDE SICKNESS; ANIMALS; ANOXIA; COGNITION DISORDERS; DENDRITES; GUANFACINE; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84885392284     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.023     Document Type: Article

References (63)

1. Adams J.A. Hypoxic brain damage. Br J Anaesth 1975, 47:121-129.
2. Arnsten A.F. Catecholamine and second messenger influences on prefrontal cortical networks of ''representational knowledge'': a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 2007, 17:6-15.
3. Arnsten A.F., Cai J.X., Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 1988, 8:4287-4298.
4. Arnsten A.F., Wang M.J., Paspalas C.D. Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 2012, 76:223-239.
5. Arnsten A.F.T. Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plast 2000, 7:133-146.
6. Arnsten A.F.T., Jin L.E. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J Biol Med 2012, 85:45-58.
7. Baitharu I., Deep S.N., Jain V., Prasad D., Ilavazhagan G. Inhibition of glucocorticoid receptors ameliorates hypobaric hypoxia induced memory impairment in rat. Behav Brain Res 2013, 240:76-86.
8. Birnbaum S.G., Podell D.M., Arnsten A.F. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol Biochem Behav 2000, 67:397-403.
9. Birnbaum S.G., Yuan P.X., Wang M., Vijayraghavan S., Bloom A.K., Davis D.J., Gobeske K.T., Sweatt J.D., Manji H.K., Arnsten A.F. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004, 306:882-884.
10. Bylund D.B. Subtypes of α2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci 1988, 9:346-361.
11. Calabrese B., Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005, 48(1):77-90.
12. Cavaletti G., Garavaglia P., Arragoni G., Tredici G. Persistent memory impairment after high altitude climbing. Int J Sports Med 1990, 11:176-178.
13. Connor D.F., Grasso D.J., Slivinsky M.D., Pearson G.S., Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol 2013, 23:244-251.
14. Deacon R.M., Rawlins J.N. T-maze alternation in rodents. Nat Protoc 2006, 1:7-12.
15. Delatour B., Gisquet-Verrier P. Functional role of rat prelimbic-infralimbic cortices in spatial memory: evidence for their involvement in attention and behavioral flexibility. Behav Brain Res 2000, 109:113-128.
16. Engelhard K., Werner C., Hoffman W.E., Matthes B., Blobner M., Kochs E. The effect of sevoflurane and propofol on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesth Analg 2003, 97:1155-1156.
17. Franowicz J.S., Kessler L.E., Borja C.M., Kobilka B.K., Limbird L.E., Arnsten A.F. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J Neurosci 2002, 22:8771-8777.
18. Friedman J.I., Adler D.N., Temporini H.D., Kemether E., Harvey P.D., White L., Parrella M., Davis K.L. Guanfacine treatment of cognitive Impairment in schizophrenia. Neuropsychopharmacology 2001, 25:402-409.
19. Garrido E., Castello A., Ventura J.L., Capdevila A., Rodríguez F.A. Cortical atrophy and other brain magnetic resonance imaging (MRI) change after extremely high altitude climbs without oxygen. Inter J Sports Med 1993, 14:232-234.
20. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
21. Hains A.B., Vu M.A., Maciejewski P.K., van Dyck C.H., Gottron M., Arnsten A.F. Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc Natl Acad Sci U S A 2009, 106:17957-17962.
22. Hardebo J.E., Owman C. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface. Ann Neurol 1980, 8:1-31.
23. Heidbredera C.A., Groenewegenb H.J. The medial prefrontal cortex in the rat: evidence for a dose-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003, 27:555-579.
24. Hering H., Sheng M. Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci 2001, 2:880-888.
25. Hu J., Vidovic M., Chen M.M., Lu Q.Y., Song Z.M. Activation of alpha 2A adrenoceptors alters dendritic spine development and the expression of spinophilin in cultured cortical neurons. Brain Res 2008, 1199:37-45.
26. Jain V., Baitharu I., Prasad D., Ilavazhagan G. Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One 2013, 8:e62235.
27. Jentsch J.D., Sanchez B.D., Elswortha J.D., Rotha R.H. Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype. Brain Res 2008, 1246:41-46.
28. Ji X.H., Ji J.Z., Zhang H., Li B.M. Stimulation of a2-Adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat. Neuropsychopharmacology 2008, 33:2263-2271.
29. Jin X.C., MA CL Li BM The α2A -adrenoceptor agonist guanfacine improves spatial learning but not fear conditioning in rats. Acta Physiol Sin 2007, 59:739-744.
30. Kiechel J.R. Pharmacokinetics and metabolism of guanfacine in man: a review. Br J Clin Pharmacol 1980, 10:25S-32S.
31. Kobori N., Clifton G.L., Dash P.K. Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction. J Neurotrauma 2006, 23:1094-10102.
32. Kobori N., Hu B., Dash P.K. Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction. Neuroscience 2011, 172:293-302.
33. Kramer A.F., Coyne J.T., Strayer D.L. Cognitive function at high altitude. Hum Factors 1993, 35:329-344.
34. Larsen J.K., Divac I. Selective ablations within the prefrontal cortex of the rat and performance of delayed alternation. Physiol Psychol 1978, 6:15-17.
35. Leuner B., Gould E. Dendritic growth in medial prefrontal cortex and cognitive flexibility are enhanced during the postpartum period. J Neurosci 2010, 30:13499-13503.
36. Lieberman P., Protopapas A., Reed E., Youngs J.W., Kanki B.G. Cognitive defects at high altitude. Nature 1994, 372:325.
37. Liston C., Miller M.M., Goldwater D.S., Radley J.J., Rocher A.B., Hof P.R., Morrison J.H., McEwen B.S. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 2006, 26:7870-7874.
38. Ma D., Hossain M., Rajakumaraswamy N., Sanders R., Franks N., Maze M. Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtype. Eur J Pharmacol 2004, 502:87-97.
39. Ma D., Rajakumaraswamy N., Maze M. α 2-Adrenoceptor agonists: shedding light on neuroprotection?. Br Med Bull 2005, 71:77-92.
40. Maiti P., Muthuraju S., Ilavazhagan G., Singh S.B. Hypobaric hypoxia induces dendritic plasticity in cortical and hippocampal pyramidal neurons in rat brain. Behav Brain Res 2008, 189:233-243.
41. Malhotra P.A., Parton A.D., Greenwood R., Husain M. Noradrenergic modulation of space exploration in visual neglect. Ann Neurol 2006, 59:186-190.
42. McAllister T.W., McDonald B.C., Flashman L.A., Ferrell R.B., Tosteson T.D., Yanofsky N.N., Grove M.R., Saykin A.J. Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response. Int J Psychophysiol 2011, 82:107-114.
43. Miner L.H., Jedema H.P., Moore F.W., Blakely R.D., Grace A.A., Sesack S.R. Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex. J Neurosci 2006, 26:1571-1578.
44. Nellgard B.M., Miura Y., Burkhard-Mackensen G., Pearlstein R.D., Warner D.S. Effect of intracerebral norepinephrine depletion on outcome from severe forebrain ischemia in the rat. Brain Res 1999, 847:262-269.
45. Pudovkina O.L., Kawahara Y., de Vries J., Westerink B.H. The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Res 2001, 906:38-45.
46. Ray K., Dutta A., Panjwani U., Thakur L., Anand J.P., Kumar S. Hypobaric hypoxia modulates brain biogenic amines and disturbs sleep architecture. Neurochem Int 2011, 58:112-118.
47. Regard M., Oelz O., Brugger P., Landis T. Persistent cognitive impairment in climbers after repeated exposure to extreme altitude. Neurology 1989, 39:210-213.
48. Ren W.W., Liu Y., Li B.M. Stimulation of α (2A)-adrenoceptors promotes the maturation of dendritic spines in cultured neurons of the medial prefrontal cortex. Mol Cell Neurosci 2012, 49:205-216.
49. Rodway G.W., Hoffman L.A., Sanders M.H. High altitude related disorders. Part- I. Pathophysiology, different diagnosis and treatment. Heart Lung 2003, 32:353-359.
50. Sahu S., Ray K., Yogendra Kumar M.S., Gupta S., Kauser H., Kumar S., Mishra K., Panjwani U. Valeriana wallichii root extract improves sleep quality and modulates brain monoamine level in rats. Phytomedicine 2012, 19:924-929.
51. Sallee F.R., McGough J., Wigal T., Donahue J., Lyne A., Biederman J. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2009, 48:155-165.
52. Salvatore M.F., Waymire J.C., Hayycock J.W. Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ. J Neurochem 2001, 79:349-360.
53. Savourey G., Launay J.C., Besnard Y., Guinet A., Travers S. Normo- and hypobaric hypoxia: are there any physiological differences?. Eur J Appl Physiol 2003, 89:122-126.
54. Shankaranayana Rao B.S., Desiraju T., Raju T.R. Neuronal plasticity induced by self-stimulation rewarding experience in rats-a study on alteration in dendritic branching in pyramidal neurons of hippocampus and motor cortex. Brain Res 1993, 627:216-224.
55. Shukitt-Hale B., Stillman M.J., Welch D.I., Levy A., Devine J.A., Lieberman H.R. Hypobaric hypoxia impairs spatial memory in an elevation dependent fashion. Behav Neural Biol 1994, 62:244-252.
56. Singh-Curry V., Malhotra P., Farmer S.F., Husain M. Attention deficits following ADEM ameliorated by guanfacine. J Neurol Neurosurg Psychiatry 2011, 82:688-690.
57. Tanila H., Mustonen K., Sallinen J., Scheinin M., Riekkinen P. Role of alpha2C-adrenoceptor subtype in spatial working memory as revealed by mice with targeted disruption of the alpha2C-adrenoceptor gene. Eur J Neurosci 1999, 11:599-603.
58. Taylor R.B., Reid R., Kendle K., Geddes C., Curle P.F. Assay procedures for the determination of biogenic amines and their metabolites in rat hypothalamus using ion-paring reverse phase high performing liquid chromatography. J Chromatogr 1983, 277:101-114.
59. Titus A.D., Shankaranarayana Rao B.S., Harsha H.N., Ramkumar K., Srikumar B.N., Singh S.B., Chattarji S., Raju T.R. Hypobaric hypoxia-induced dendritic atrophy of hippocampal neurons is associated with cognitive impairment in adult rats. Neuroscience 2007, 145(1):265-278.
60. Trouvin J.H., Prioux-Guyonneau M., Cohen Y., Jacquot C. Rat brain monoamine metabolism and hypobaric hypoxia: a new approach. Gen Pharmacol 1986, 17:69-73.
61. Wang M., Ramos B.P., Paspalas C.D., Shu Y., Simen A., Duque A., Vijayraghavan S., Brennan A., Dudley A., Nou E., Mazer J.A., McCormick D.A., Arnsten A.F. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007, 129:397-410.
62. Wilson M.H., Newman S., Imray C.H. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009, 8:175-191.
63. Zhang Y., Kimelberg H.K. Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia. Curr Neuropharmacol 2005, 3:317-323.